3.1. HPLC pre-screening analysis
In this pre-screening study, the bioactive constituents such as phenolic and flavonoids in C. gigantea leaf extract solution were determined. The graph captured several main peaks corresponding to retention time of 3.937 min, 6.659 min and 6.771 min (Table 2.0). Most prominent and sharp intensity peak of Quercetin bioactive compound was detected at 6.659 min [64] (Figure S1; Supplementary material). Some minor peaks at RT of 3.937 and 6.771 might be attributed to the presence of Vanillin and Benzoic acid, respectively [30]. The FTIR and UV-vis results from previous study agree with the finding of formation of flavonoid compound during green synthesis [28]. In the presence of high content of Quercetin phytocompound in C. gigantea leaf extract solution, antibacterial properties and antioxidant activities were further improved [65]. Quercetin bioactive compound belongs to flavonoid group of polyphenols with molecular formula of C15H10O7. Naturally, it has many promising characteristics such as anticancer, antiviral, antifungal, antimicrobial, anti-inflammatory and antioxidant. In this study, we believed that the Quercetin phytocompound play an important role in promoting synergistic antibacterial activity towards MDR and non-MDR skin pathogens [28, 66].
Table 2.0
Several main peaks corresponding to retention time (RT).
Peak #
|
RT (min)
|
Area (%)
|
Height (%)
|
1
|
3.937
|
10.472
|
1.916
|
2
|
6.659
|
63.019
|
89.106
|
3
|
6.771
|
26.269
|
8.956
|
4
|
8.643
|
0.240
|
0.022
|
3.2. Physical appearance and pH determination
Porous Cs and Cs biopolymer containing 1 wt.% of binary green-synthesized nanocomposites (ZnO/CuO) samples, were fabricated by freeze-thawing process appears in white and greyish white, respectively. Both samples show a strong acidic pH between 4.50 and 4.69. Incorporation of 1 wt.% of binary green-synthesized ZnO/CuO nanocomposites in Cs biopolymer slightly increase the pH. Enhanced antibacterial effect and speed wound recovery could be achieved by creating an acidic environment. This could be explained that, an acidic pH level might accelerate wound healing by fighting against wound infection, boosting bactericidal activity, improving re-epithelization and angiogenesis [67]. Previous studies reported that, the transparent acidic Chitosan + 75%Honey sample with pH level of 4.34 had highest ZOI towards P. aeruginosa, S. aureus, K. pneumonia and S. pyogenes and it also has highest healing rate of burn wounds [68]. Other than that, ZnO QDs has rapid dissolution and release of zinc ions and excellent bactericidal effect at pH below than 5.5 [69].
3.3. Storage analysis
The storage analysis (Tables 3.0 and Table 4.0) revealed that, the different storage temperature (25 and 4°C) and different storage time (1 and 2 months) of the Cs and ZnO/CuO-Cs-1wt.% samples were able to tune the bactericidal performance against multi-drug resistant pathogen (MRSA). Particularly, the 1 month treated-storage group (ZnO/CuO-Cs-1wt.%) at different storage temperature exhibited a significant antibacterial effect with low optical density between 0.37 ± 0.05 and 0.48 ± 0.06, while control MRSA strain showed highest absorbance of 0.95 ± 0.04. The material shelf life might be deteriorated if it is kept at longer period. So far very limited research works only investigated on bactericidal performance of storage condition-dependent wound dressing material [32].
Table 3.0
Absorbance for storage room temperature at different storage time (1 and 2 months).
Stored at room temperature
|
Sample
|
1 month
|
2 months
|
Control MRSA
|
0.95 ± 0.04
|
0.93 ± 0.01
|
Cs
|
0.8 ± 0.05
|
0.85 ± 0.08
|
ZnO/CuO-Cs-1wt.%
|
0.37 ± 0.05
|
0.49 ± 0.09
|
Table 4.0
Absorbance for freezing temperature at different storage time (1 and 2 months).
Stored at 4°C inside freezer
|
Sample
|
1 month
|
2 months
|
Control MRSA
|
0.95 ± 0.04
|
0.93 ± 0.01
|
Cs
|
0.55 ± 0.01
|
0.97 ± 0.02
|
ZnO/CuO-Cs-1wt.%
|
0.48 ± 0.06
|
0.53 ± 0.16
|
3.4. Biodegradation study
Degradation rate (%) of the prepared biomaterials are depicted in Table 5.0. The degradation rate for Cs, ZnO/CuO-Cs-1wt.% and commercial control samples were 100 ± 0.00, 100 ± 0.00 and 50.35 ± 11.20%, respectively. The degradation rate of ZnO/CuO-Cs-1wt.% sample was greater than commercial control sample where it could be fully dissolved in 8 days, while commercial control sample degraded partially. As per observed, the percentage of degradation of these samples were time-dependent and increases proportionally. In the present study, we found that the pure Cs sample was degraded partially at 3 hours of immersion time and fully dissolved at 8 hours of immersion time which may indicate that pure Cs without an addition of green-synthesized binary nanocomposites has very weak polymer chain and structural properties resulting in prominent degradation rate. Based on our findings, ZnO/CuO-Cs-1wt.% sample were highly swelled on 1–2 days of immersion time and the water content of the sample cannot be fully dabbed with tissue paper where it might destroy the nanoparticulated polymer structures. However, ZnO/CuO-Cs-1wt.% sample have considerable biodegradation properties which play an important role in eliminating medical waste and create green environment without soil pollution.
Table 5.0
Degradation (%) of the prepared biomaterials.
Sample
|
Degradation (%)
|
4 Days
|
6 Days
|
8 Days
|
Cs
|
100 ± 0.00
|
100 ± 0.00
|
100 ± 0.00
|
ZnO/CuO-Cs-1wt.%
|
17.18 ± 13.44
|
82.17 ± 5.65
|
100 ± 0.00
|
Ag-Alg
|
1.19 ± 0.32
|
29.36 ± 20.82
|
50.35 ± 11.20
|
3.5. In vitro cytocompatibility investigation at different incubation time
The investigation of nanoparticulated polymer biomaterial (ZnO/CuO-Cs-1wt.%) in vitro was studied against fibroblast cell line at different incubation time (24, 48 and 72 hours) and the results are depicted in Fig. 1.0. These results demonstrated that, (ZnO/CuO-Cs-1wt.%) sample had no apparent cytotoxic effects (~ 169%) along with normal elongated filopodia cell morphology at 72 hours treatment, indicating that this bactericidal and wound healing agent owned an excellent wound closure rate and cytocompatibility nature. This was owing to the high porosity and improved swelling characteristic of ZnO/CuO-Cs-1wt.% sample which increases absorption capacity of exudate from chronic wounds and provides passages for intake of nutrients and body fluid for wound recovery and re-epithelization [70].
Besides of that, successful control on steady and slow release of free radicals such as •O2− and •OH− from this ZnO/CuO-Cs-1wt.% nanocomposites might present with cytocompatibility properties towards human cells and can accelerate wound healing properties [71]. We believed that, smaller size irregular oval and quasi-spherical shape green-synthesized binary 75ZnO/25CuO-300C nanocomposites might further accelerate controllable amounts of metal ions release and promote cell proliferation [58, 72]. In line with this study, pure Cs sample exhibited cell viability of 129%, which was slightly lower to the (ZnO/CuO-Cs-1wt.%) sample, while the negative control does not promote the cell's augmentation. Collectively, these outcomes exhibited that ZnO/CuO-Cs-1wt.% would be suitable candidates for wound healing application.
3.6. In vitro wound healing profile: scratch assay
The wound healing efficacy of an optimized ZnO/CuO-Cs-1wt.% nanocomposites sample was further evaluated against fibroblast cell lines at different time intervals (12 and 24 hours). The findings on wound closure (%) and cell migration rate over time was shown in Table 6.0 and Fig. 2.0. The wound closure for ZnO/CuO-Cs-1wt.% nanocomposite is equivalent to the commercial control (Ag-Alg) which is around 62% at 12 hours. Meanwhile, a slightly improved wound healing extent (45%) were seen in the pure Cs group in comparison with the cell control (L929). This might be linked to the release of positively charged Ca ions (Ca2+) from Cs polymer, which was revealed from EDAX, XRD and ICP analysis [29]. These ions might help in promoting cell proliferation and wound healing [73]. But it was noted that, all treated groups have complete wound closure at 24 hours except negative control has shown no sign of wound healing. Rapid wound closure rate was clearly seen for the ZnO/CuO-Cs-1wt.% treated group. Moreover, ZnO/CuO-Cs-1wt.% treated group has exhibited remarkable cell migration rate of 26.81 µm/h at 12 hours. This might be due to the effectiveness of optimized ZnO/CuO-Cs-1wt.% biomaterial in stimulating wound healing and angiogenesis process via synergistic activity with presence of multiple ionic system (Cu2+, Zn2+ and Ca2+) [58, 74, 75] and hydrophilic nature of Cs molecules as it was proven before in contact angle analysis [76]. From the above discussion, it was clear that ZnO/CuO-Cs-1wt.% has remarkable wound healing characteristic for biomedical applications.
Table 6.0
Wound closure (%) and cell migration rate for different control and treatment group against fibroblast cell lines. “NA” symbolizes as no wound closure was observed.
Sample
|
Wound closure
(%)
|
Cell migration rate
(µm/h)
|
L929 Control
|
42.56 ± 7.41
|
21.8
|
Cs
|
45.95 ± 0.76
|
14.45
|
ZnO/CuO-Cs-1wt.%
|
62.35 ± 9.46
|
26.81
|
Commercial Control
|
62.80 ± 5.86
|
23.39
|
DMSO Control
|
NA
|
NA
|
3.7. In vivo wound healing profile: excisional open wound in animal SD rats
In this work, Cs biopolymer containing 1 wt.% of binary green-synthesized nanocomposites (ZnO/CuO) sample has shown remarkable wound closure rate within 14 days. The efficacy of wound dressing material was investigated in the SD rats wound model (n = 3). Changes on initial wound area at day 3, 7, 11 and 14 were observed and captured as shown in Fig. 3.0. Dry surface and scab formation without accumulation of pus were clearly seen for all created wounds after administration of dressing material. Bare/blank control group and Cs control group exhibited slower wound healing than other treated groups. However, by day 3 the wound healing for ZnO/CuO-Cs-1wt.% treated group showed faster reduction in wound closure (44.05 ± 4.77%) while bare/blank control, Cs control and commercial positive control treated groups have lower wound closure rate which was approximately between 20.63 ± 7.99 and 28.41 ± 8.29%. This could be explained due to the high porosity and swelling index of porous Cs biopolymer containing 1 wt.% of binary green-synthesized nanocomposites (ZnO/CuO) than Cs control and commercial positive control [29].
The average wound closure rate (%) on day 14 was 75.64 ± 7.83 in the bare/blank control group, 80.86 ± 2.18 in the commercial positive control group, 75.58 ± 2.60 in the Cs control group and 86.44 ± 6.48 in the ZnO/CuO-Cs-1wt.% treated group. Among all groups, wound treated with biodegradable porous ZnO/CuO-Cs-1wt.% nanocomposites provide an ideal wound healing environment and superficial fibroblast proliferation. Thus, low-concentrated Cu, Zn an Ca ions play an important role in stimulating cell migration in open wound [58, 72]. In all treated SD rats, there was no evidence of behavioral sign of illness or pain such as guarding, vocalizing, biting, restlessness, abnormal resting position, failure to groom, lack of mobility. All experimental SD rats administrated with ZnO/CuO-Cs-1wt.% displayed “0” grimace scale, and there were no treatment related morbidity and mortality. Besides of that, no any abnormalities were seen on the skin, fur, eyes, mucous membrane, stool and urine for all treated group of SD rats.
Moreover, the use of ZnO/CuO-Cs-1wt.% is advantageous to increase the material absorption on wound area through melting and slow degradation, whereas the positive control hardly absorbed on wound surface due to the slow degradation as positively captured in biodegradation study (Figure S2; Supplementary material). In addition, all SD rats gained their body weight during 14 days of treatment period (Fig. 4.0a). No significant differences were captured in food and water intake for all treated and bare control group during the treatment period (Figs. 4.0b and 4.0c). All harvested major internal organs such as spleen, kidneys, heart, lungs and liver were identically healthy and revealed normal morphological appearance in term of size, shape and colour without any tumor growth and swelling (Fig. 5.0).
Previously, several studies have shown that the formulated wound healing agent such as AMP- and CeON-loaded catechol-modified hydrogel [6], Chitosan-based hydrogel with MOF-loaded α-lipoic acid [15], Chitosan/poloxamer-based thermosensitive hydrogels containing zinc gluconate/recombinant human epidermal growth factor [16] and Ag-PCL/GelMA fibrous membranes [26] dramatically cured the created initial wound size (0.8–1.5 cm in diameter) within 11 to 21 days. However, this developed biodegradable porous ZnO/CuO-Cs-1wt.% nanocomposites in the current work were found to be best formulation than other reported wound dressing products, since it managed to heal the larger size (square shape: 2cmᵡ2cm) of created wound on day 0 quickly in total 14 days. Conclusively, this developed green wound dressing has emerged a promising potential in biomaterials for open wound healing application.
3.8. Multiple metal ion release
The release of Zn, Cu and natural Ca ion derivatives concentration in deionized water were quantified in line with the material degradation at Day 1 and Day 3. Concentration of metal oxide ions was a very important factor in promoting synergistic killing activity towards skin pathogens. It could be seen from Fig. 6.0 that the dissolution of Zn and Cu ions was slightly affected by the different immersion days of biodegradable porous ZnO/CuO-Cs-1wt.% nanocomposites. The detected Zn, Cu and Ca concentration after immersion of 3 days for ZnO/CuO-Cs-1wt.% nanocomposites sample were 3.23 ± 0.063 mg/L, 0.37 ± 0.014 mg/L and 2.09 ± 0.042 mg/L, respectively. It demonstrates that, Zn and Ca ions release concentration peaked on day 1 and then gradually declined after 3 days. The rate of metal oxide ions (i. e., Zn2+ and Ca2+) release slightly reduced with longer immersion days [77]. The detected Zn concentration was significantly higher than Cu and Ca element due to the high reactivity and solubility of ZnO in deionized water. Conclusively, these multiple metal ions derivatives release from nanocomposites could be a viable solution to combat antibiotic resistance by killing the skin pathogens.